Average Co-Inventor Count = 5.48
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Sciences Ireland Uc (23 from 111 patents)
2. Janssen Sciences Ireland Unlimited Company (6 from 60 patents)
3. Janssen R&d Ireland (5 from 45 patents)
4. Tibotec Pharmaceuticals Ltd. (2 from 66 patents)
5. Janssen Research & Development Ireland (1 from 1 patent)
37 patents:
1. 11541050 - Pyrimidine derivatives for the treatment of viral infections
2. 11491148 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
3. 11220504 - Pyrrolo[3,2-d] pyrimidine derivatives for the treatment of viral infections and other diseases
4. 11096931 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
5. 11078193 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
6. 10995064 - Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
7. 10941113 - Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
8. 10875876 - Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
9. 10780089 - Pyrimidine derivatives for the treatment of viral infections
10. 10781216 - Pyrrolo [3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
11. 10723707 - Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections
12. 10676429 - Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
13. 10457638 - Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
14. 10420767 - Pyrimidine derivatives for the treatment of viral infections
15. 10398677 - N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B